他汀类药物在子痫前期预防中的作用
子痫前期是常见妊娠期高血压疾病,与新生儿和孕产妇并发症及死亡相关。他汀类药物可纠正子痫前期的病理生理通路,普伐他汀在临床前和临床研究中显示可逆转血管生成失衡、恢复内皮健康并预防氧化和炎症损伤,人体研究显示其安全性良好,近期证据不支持既往致畸担忧。基于初步研究的积极发现和强生物学合理性,他汀类药物应在大型随机对照临床试验中研究用于预防子痫前期。
要点
- 普伐他汀在临床前和临床研究中可逆转子痫前期相关的妊娠特异性血管生成失衡。
- 人体研究显示普伐他汀安全性良好,近期证据不支持既往对他汀类妊娠致畸的担忧。
- 他汀类药物应在大型随机对照临床试验中研究用于预防子痫前期。
核心结论
- 基于初步研究的积极发现和强生物学合理性,他汀类药物应在大型随机对照临床试验中研究用于预防子痫前期。
研究设计与样本
- 综述,未报告检索范围。
主要发现
- 子痫前期是常见妊娠期高血压疾病,与相当的新生儿和孕产妇并发症及死亡相关。
- 子痫前期确切病因未知,普遍认为异常胎盘形成导致可溶性抗血管生成因子释放,加上氧化应激和炎症增加,引起全身内皮功能障碍和疾病临床表现。
- 他汀类药物可纠正子痫前期发生相关的相似病理生理通路。
- 普伐他汀在多项临床前和临床研究中被报告可逆转子痫前期相关的妊娠特异性血管生成失衡、恢复整体内皮健康并预防氧化和炎症损伤。
- 人体研究发现普伐他汀安全性良好,近期证据不支持既往他汀类妊娠致畸担忧。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Preeclampsia is a common hypertensive disorder of pregnancy associated with considerable neonatal and maternal morbidities and mortalities. However, the exact cause of preeclampsia remains unknown; it is generally accepted that abnormal placentation resulting in the release of soluble antiangiogenic factors, coupled with increased oxidative stress and inflammation, leads to systemic endothelial dysfunction and the clinical manifestations of the disease. Statins have been found to correct similar pathophysiological pathways that underlie the development of preeclampsia. Pravastatin, specifically, has been reported in various preclinical and clinical studies to reverse the pregnancy-specific angiogenic imbalance associated with preeclampsia, to restore global endothelial health, and to prevent oxidative and inflammatory injury. Human studies have found a favorable safety profile for pravastatin, and more recent evidence does not support the previous teratogenic concerns surrounding statins in pregnancy. With reassuring and positive findings from pilot studies and strong biological plausibility, statins should be investigated in large clinical randomized-controlled trials for the prevention of preeclampsia.
引用
- Smith DD, Costantine MM. The role of statins in the prevention of preeclampsia. Am J Obstet Gynecol. 2020. PMID: 32818477. doi:10.1016/j.ajog.2020.08.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。